Cofactor Mimics as Selective Inhibitors of NAD-dependent Inosine Monophospate Dehydrogenase (IMPDH) - the Major Therapeutic Target

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|11|7|887-900

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.11, Iss.7, 2004-04, pp. : 887-900

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inosine 5'-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 18, Iss. 8, 2018-04 ,pp. : 656-671

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances on the Enantioselective Synthesis of C-Nucleosides Inhibitors of Inosine Monophosphate Dehydrogenase (IMPDH)

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 10, 2014-05 ,pp. : 1212-1224

Bentham Science Publishers

Access to resources Recommend Favorite

NAD+ Metabolism and NAD+-Dependent Enzymes: Promising Therapeutic Targets for Neurological Diseases

By  

Current Drug Targets, Vol. 13, Iss. 2, 2012-02 ,pp. : 222-229

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and Optimization of NAD+-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds

By  

Current Pharmaceutical Design, Vol. 23, Iss. 14, 2017-05 ,pp. : 2117-2130

Bentham Science Publishers

Access to resources Recommend Favorite

NAD+/NADH Metabolism and NAD+-Dependent Enzymes in Cell Death and Ischemic Brain Injury: Current Advances and Therapeutic Implications

By  

Current Medicinal Chemistry, Vol. 22, Iss. 10, 2015-01 ,pp. : 1239-1247

Bentham Science Publishers

Access to resources Recommend Favorite